Once upon a time, in a world that now feels as distant as a fairy tale, Queensland Health, in collaboration with three of the state’s top universities –UQ, Griffith, and JCU – established the Queensland Covid-19 Vaccination Safety and Efficacy Trial (QoVAX SET).
Led by Professor Janet Davies, the study set out to track immune responses and identify factors affecting vaccine safety and efficacy across a broad and diverse population including Aboriginal and Torres Strait Islanders, minority ethnic groups, the sick as well as the healthy, and even the unvaccinated.
Already a subscriber? Log in
Subscribe for just $2 a week
Try a month of The Spectator Australia absolutely free and without commitment. Not only that but – if you choose to continue – you’ll pay just $2 a week for your first year.
- Unlimited access to spectator.com.au and app
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Unlock this article
You might disagree with half of it, but you’ll enjoy reading all of it. Try your first month for free, then just $2 a week for the remainder of your first year.
Comments
Don't miss out
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
SUBSCRIBEAlready a subscriber? Log in